BioCentury | Mar 16, 2015
Finance

Chiasma's private decision

...is president and CEO of Geron Corp. and was previously CEO at Proteolix Inc. and Tercica Inc....
BioCentury | May 7, 2012
Strategy

Jazz's big band sound

...SVP and CCO at Ipsen Group and had been VP of marketing at endocrine/metabolic company Tercica Inc....
BioCentury | Apr 2, 2012
Company News

Vivus management update

...as senior director of clinical development, formerly VP of clinical development at Ipsen Group 's Tercica Inc....
BioCentury | Jan 23, 2012
Company News

Insmed sales and marketing update

...it needed to conserve supply for existing patients. Under a settlement with Genentech Inc. and Tercica Inc....
...the product for severe insulin resistance, myotonic muscular dystrophy (MMD) and HIV-associated adipose redistribution syndrome. Tercica...
BioCentury | Jan 9, 2012
Finance

A Remembrance: An authentic giant

...Geron Corp. I first met Alex in 2001, when I co-founded Tercica. Alex invested in Tercica's...
BioCentury | Oct 10, 2011
Finance

Venture's stress

...amount SurgRx Inc. 2002 Acquired by Johnson & Johnson (NYSE:JNJ) in Oct 2008 for $285M Tercica Inc....
BioCentury | Dec 20, 2010
Company News

Ipsen, Merck KGaA sales and marketing update

...Merck's EMD Serono Inc. affiliate received exclusive, Canadian rights from Ipsen's Tercica Inc. subsidiary to market Somatuline...
BioCentury | Dec 6, 2010
Company News

Insmed, Transave deal

...it for the indication under the settlement of a patent dispute with Genentech Inc. and Tercica Inc....
...such as retinopathy of prematurity, but the company is not developing any other late-stage compounds. Tercica...
BioCentury | Dec 3, 2010
Company News

Insmed combines with Transave

...it for the indication under the settlement of a patent dispute with Genentech Inc. and Tercica Inc....
...such as retinopathy of prematurity, but the company does not have any other late-stage compounds. Tercica...
BioCentury | Apr 12, 2010
Company News

AcelRx management update

...Drug delivery Hired: Richard King as president and CEO, formerly president and general manager of Tercica Inc....
Items per page:
1 - 10 of 233
BioCentury | Mar 16, 2015
Finance

Chiasma's private decision

...is president and CEO of Geron Corp. and was previously CEO at Proteolix Inc. and Tercica Inc....
BioCentury | May 7, 2012
Strategy

Jazz's big band sound

...SVP and CCO at Ipsen Group and had been VP of marketing at endocrine/metabolic company Tercica Inc....
BioCentury | Apr 2, 2012
Company News

Vivus management update

...as senior director of clinical development, formerly VP of clinical development at Ipsen Group 's Tercica Inc....
BioCentury | Jan 23, 2012
Company News

Insmed sales and marketing update

...it needed to conserve supply for existing patients. Under a settlement with Genentech Inc. and Tercica Inc....
...the product for severe insulin resistance, myotonic muscular dystrophy (MMD) and HIV-associated adipose redistribution syndrome. Tercica...
BioCentury | Jan 9, 2012
Finance

A Remembrance: An authentic giant

...Geron Corp. I first met Alex in 2001, when I co-founded Tercica. Alex invested in Tercica's...
BioCentury | Oct 10, 2011
Finance

Venture's stress

...amount SurgRx Inc. 2002 Acquired by Johnson & Johnson (NYSE:JNJ) in Oct 2008 for $285M Tercica Inc....
BioCentury | Dec 20, 2010
Company News

Ipsen, Merck KGaA sales and marketing update

...Merck's EMD Serono Inc. affiliate received exclusive, Canadian rights from Ipsen's Tercica Inc. subsidiary to market Somatuline...
BioCentury | Dec 6, 2010
Company News

Insmed, Transave deal

...it for the indication under the settlement of a patent dispute with Genentech Inc. and Tercica Inc....
...such as retinopathy of prematurity, but the company is not developing any other late-stage compounds. Tercica...
BioCentury | Dec 3, 2010
Company News

Insmed combines with Transave

...it for the indication under the settlement of a patent dispute with Genentech Inc. and Tercica Inc....
...such as retinopathy of prematurity, but the company does not have any other late-stage compounds. Tercica...
BioCentury | Apr 12, 2010
Company News

AcelRx management update

...Drug delivery Hired: Richard King as president and CEO, formerly president and general manager of Tercica Inc....
Items per page:
1 - 10 of 233